previous recorded in 3Q.2019, due to an increase in bank loans to acquire new portfolios and short-term loans for working capital. ● Interest and discount on promissory notes in 4Q.2019 was lower by 52.82

related transactions between the Company and the director, management and direct and indirect shareholders exceeding 10% The details are shown as the attachment. The Company is confirmed that all

”). The details of the Transaction are as follows; 1. Acquisition of NEXT Ordinary Shares from the Seller The Company shall acquire 4,750,000 shares at par value of 10 Baht per share, equivalent to 100.00

“Transaction”). The details of the Transaction are as follows; 1. Acquisition of NEXT Ordinary Shares from the Seller The Company shall acquire 4,750,000 shares at par value of 10 Baht per share, equivalent to

total voting rights, regardless of direct shareholding or through the form of downward shareholding chain of which each level is other juristic person similar to the one stated in (3) and its shares are

is a subsidiary of the Company, on Letter of Intention “LOI” to acquire franchise from Wuttisak Clinic Inter. Group Co., Ltd. (“WCIG”), ”), which is an indirect subsidiary of E FOR L AIM Public Co

Center Co., Ltd. (“HHC”), which is a subsidiary of the Company, on Letter of Intention “LOI” to acquire franchise from Wuttisak Clinic Inter. Group Co., Ltd. (“WCIG”), ”), which is an indirect subsidiary

Public Company Limited (“IVL” or the “Company”) held on 11 th May 2018, has approved Indorama Netherlands B.V. its indirect subsidiary to further acquire 24 % equity stake in PT. Indorama Petrochemicals, a

further acquire the remaining 26% equity stake in PT. Indorama Petrochemicals (“PTIP”), a PTA manufacturing plant in Indonesia from PT. Indo-Rama Synthetics Tbk., a connected party. Rationale of the

for this Investment is from the capital increase of Oventure Pte. Ltd. and the Company will utilize such fund to acquire the maximum amount of shares up to 26% in BCB (i.e. acquisition of new shares up